Phase 2 Leukaemia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing to take part voluntarily and have signed a written consent form (or whose legal guardian has signed on their behalf), and who are willing to follow all study procedures
- People aged 14 to 60 years at the time of screening, of any gender
- People who have been diagnosed with acute monocytic leukemia (a specific type of blood cancer, classified according to 2016 WHO standards), not including a subtype called acute promyelocytic leukemia
- People with no history of severe allergic reactions
- People whose liver is functioning within acceptable ranges, based on specific blood test results (ALT, AST, and bilirubin levels — confirm with trial site)
- People whose kidneys are functioning within acceptable ranges, based on a specific blood test (serum creatinine level — confirm with trial site)
- People who do not have an uncontrolled infection or a severe psychiatric (mental health) disorder
- People who are reasonably well and mobile, rated 0–3 on a standard health scale used by doctors (confirm with trial site), with a life expectancy of at least 4 months
Who may not be able to join:
- People who are known to be allergic to, or medically unsuitable for, any of the study drugs
- People who are pregnant or currently breastfeeding
- People who have an active infection at the time of joining
- People with a history of long-term heavy smoking or alcohol use that could affect how study results are measured
- People with a psychiatric illness or other condition that would make it difficult to give informed consent or follow study procedures
- People who have had major surgery on an organ within 6 weeks before enrolling in the trial
- People whose liver or kidney function test results fall outside the acceptable ranges set by the trial (confirm with trial site)
- People whom the trial investigator considers unsuitable for any reason, such as concerns about ability to follow the study requirements or substance use
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Liping Dou, Doctor, Chinese PLA General Hospital
Phone: +8613681207138
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Composite Complete Remission Rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.